2022-12-012023-11-302023-11-30false00686142ALAN STOCKLEY & COMPANY LIMITED2024-08-27iso4217:GBPxbrli:pure006861422022-12-01006861422023-11-30006861422022-12-012023-11-30006861422022-05-01006861422022-11-30006861422022-05-012022-11-3000686142bus:SmallEntities2022-12-012023-11-3000686142bus:AuditExempt-NoAccountantsReport2022-12-012023-11-3000686142bus:FullAccounts2022-12-012023-11-3000686142bus:PrivateLimitedCompanyLtd2022-12-012023-11-3000686142core:WithinOneYear2023-11-3000686142core:AfterOneYear2023-11-3000686142core:WithinOneYear2022-11-3000686142core:AfterOneYear2022-11-3000686142core:ShareCapital2023-11-3000686142core:SharePremium2023-11-3000686142core:RevaluationReserve2023-11-3000686142core:OtherReservesSubtotal2023-11-3000686142core:RetainedEarningsAccumulatedLosses2023-11-3000686142core:ShareCapital2022-11-3000686142core:SharePremium2022-11-3000686142core:RevaluationReserve2022-11-3000686142core:OtherReservesSubtotal2022-11-3000686142core:RetainedEarningsAccumulatedLosses2022-11-3000686142core:LandBuildings2023-11-3000686142core:PlantMachinery2023-11-3000686142core:Vehicles2023-11-3000686142core:FurnitureFittings2023-11-3000686142core:OfficeEquipment2023-11-3000686142core:NetGoodwill2023-11-3000686142core:IntangibleAssetsOtherThanGoodwill2023-11-3000686142core:ListedExchangeTraded2023-11-3000686142core:UnlistedNon-exchangeTraded2023-11-3000686142core:LandBuildings2022-11-3000686142core:PlantMachinery2022-11-3000686142core:Vehicles2022-11-3000686142core:FurnitureFittings2022-11-3000686142core:OfficeEquipment2022-11-3000686142core:NetGoodwill2022-11-3000686142core:IntangibleAssetsOtherThanGoodwill2022-11-3000686142core:ListedExchangeTraded2022-11-3000686142core:UnlistedNon-exchangeTraded2022-11-3000686142core:LandBuildings2022-12-012023-11-3000686142core:PlantMachinery2022-12-012023-11-3000686142core:Vehicles2022-12-012023-11-3000686142core:FurnitureFittings2022-12-012023-11-3000686142core:OfficeEquipment2022-12-012023-11-3000686142core:NetGoodwill2022-12-012023-11-3000686142core:IntangibleAssetsOtherThanGoodwill2022-12-012023-11-3000686142core:ListedExchangeTraded2022-12-012023-11-3000686142core:UnlistedNon-exchangeTraded2022-12-012023-11-3000686142core:MoreThanFiveYears2022-12-012023-11-3000686142core:Non-currentFinancialInstruments2023-11-3000686142core:Non-currentFinancialInstruments2022-11-3000686142dpl:CostSales2022-12-012023-11-3000686142dpl:DistributionCosts2022-12-012023-11-3000686142core:LandBuildings2022-12-012023-11-3000686142core:PlantMachinery2022-12-012023-11-3000686142core:Vehicles2022-12-012023-11-3000686142core:FurnitureFittings2022-12-012023-11-3000686142core:OfficeEquipment2022-12-012023-11-3000686142dpl:AdministrativeExpenses2022-12-012023-11-3000686142core:NetGoodwill2022-12-012023-11-3000686142core:IntangibleAssetsOtherThanGoodwill2022-12-012023-11-3000686142dpl:GroupUndertakings2022-12-012023-11-3000686142dpl:ParticipatingInterests2022-12-012023-11-3000686142dpl:GroupUndertakingscore:ListedExchangeTraded2022-12-012023-11-3000686142core:ListedExchangeTraded2022-12-012023-11-3000686142dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-12-012023-11-3000686142core:UnlistedNon-exchangeTraded2022-12-012023-11-3000686142dpl:CostSales2022-05-012022-11-3000686142dpl:DistributionCosts2022-05-012022-11-3000686142core:LandBuildings2022-05-012022-11-3000686142core:PlantMachinery2022-05-012022-11-3000686142core:Vehicles2022-05-012022-11-3000686142core:FurnitureFittings2022-05-012022-11-3000686142core:OfficeEquipment2022-05-012022-11-3000686142dpl:AdministrativeExpenses2022-05-012022-11-3000686142core:NetGoodwill2022-05-012022-11-3000686142core:IntangibleAssetsOtherThanGoodwill2022-05-012022-11-3000686142dpl:GroupUndertakings2022-05-012022-11-3000686142dpl:ParticipatingInterests2022-05-012022-11-3000686142dpl:GroupUndertakingscore:ListedExchangeTraded2022-05-012022-11-3000686142core:ListedExchangeTraded2022-05-012022-11-3000686142dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-05-012022-11-3000686142core:UnlistedNon-exchangeTraded2022-05-012022-11-3000686142core:NetGoodwill2023-11-3000686142core:IntangibleAssetsOtherThanGoodwill2023-11-3000686142core:LandBuildings2023-11-3000686142core:PlantMachinery2023-11-3000686142core:Vehicles2023-11-3000686142core:FurnitureFittings2023-11-3000686142core:OfficeEquipment2023-11-3000686142core:AfterOneYear2023-11-3000686142core:WithinOneYear2023-11-3000686142core:ListedExchangeTraded2023-11-3000686142core:UnlistedNon-exchangeTraded2023-11-3000686142core:ShareCapital2023-11-3000686142core:SharePremium2023-11-3000686142core:RevaluationReserve2023-11-3000686142core:OtherReservesSubtotal2023-11-3000686142core:RetainedEarningsAccumulatedLosses2023-11-3000686142core:NetGoodwill2022-11-3000686142core:IntangibleAssetsOtherThanGoodwill2022-11-3000686142core:LandBuildings2022-11-3000686142core:PlantMachinery2022-11-3000686142core:Vehicles2022-11-3000686142core:FurnitureFittings2022-11-3000686142core:OfficeEquipment2022-11-3000686142core:AfterOneYear2022-11-3000686142core:WithinOneYear2022-11-3000686142core:ListedExchangeTraded2022-11-3000686142core:UnlistedNon-exchangeTraded2022-11-3000686142core:ShareCapital2022-11-3000686142core:SharePremium2022-11-3000686142core:RevaluationReserve2022-11-3000686142core:OtherReservesSubtotal2022-11-3000686142core:RetainedEarningsAccumulatedLosses2022-11-3000686142core:NetGoodwill2022-05-0100686142core:IntangibleAssetsOtherThanGoodwill2022-05-0100686142core:LandBuildings2022-05-0100686142core:PlantMachinery2022-05-0100686142core:Vehicles2022-05-0100686142core:FurnitureFittings2022-05-0100686142core:OfficeEquipment2022-05-0100686142core:AfterOneYear2022-05-0100686142core:WithinOneYear2022-05-0100686142core:ListedExchangeTraded2022-05-0100686142core:UnlistedNon-exchangeTraded2022-05-0100686142core:ShareCapital2022-05-0100686142core:SharePremium2022-05-0100686142core:RevaluationReserve2022-05-0100686142core:OtherReservesSubtotal2022-05-0100686142core:RetainedEarningsAccumulatedLosses2022-05-0100686142core:AfterOneYear2022-12-012023-11-3000686142core:WithinOneYear2022-12-012023-11-3000686142core:Non-currentFinancialInstrumentscore:CostValuation2022-12-012023-11-3000686142core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-12-012023-11-3000686142core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-12-012023-11-3000686142core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-12-012023-11-3000686142core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-12-012023-11-3000686142core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-12-012023-11-3000686142core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-12-012023-11-3000686142core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-12-012023-11-3000686142core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-12-012023-11-3000686142core:Non-currentFinancialInstrumentscore:CostValuation2023-11-3000686142core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-11-3000686142core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-11-3000686142core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-11-3000686142core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-11-3000686142core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-11-3000686142core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-11-3000686142core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-11-3000686142core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-11-3000686142core:Non-currentFinancialInstrumentscore:CostValuation2022-11-3000686142core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-11-3000686142core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-11-3000686142core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-11-3000686142core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-11-3000686142core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-11-3000686142core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-11-3000686142core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-11-3000686142core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-11-3000686142bus:Director12022-12-012023-11-30

ALAN STOCKLEY & COMPANY LIMITED

Registered Number
00686142
(England and Wales)

Unaudited Financial Statements for the Year ended
30 November 2023

ALAN STOCKLEY & COMPANY LIMITED
Company Information
for the year from 1 December 2022 to 30 November 2023

Director

Mr Benjamin AMPOMAH

Registered Address

The Pharmacy
37 Lynn Road Snettisham
Kings Lynn
PE31 7LR

Registered Number

00686142 (England and Wales)
ALAN STOCKLEY & COMPANY LIMITED
Balance Sheet as at
30 November 2023

Notes

2023

2022

£

£

£

£

Fixed assets
Tangible assets342,05141,294
42,05141,294
Current assets
Stocks479,22262,350
Debtors5900,875796,483
Cash at bank and on hand77,732107,140
1,057,829965,973
Creditors amounts falling due within one year6(466,915)(424,512)
Net current assets (liabilities)590,914541,461
Total assets less current liabilities632,965582,755
Creditors amounts falling due after one year7(23,174)(33,333)
Net assets609,791549,422
Capital and reserves
Called up share capital2,0002,000
Profit and loss account607,791547,422
Shareholders' funds609,791549,422
The financial statements were approved and authorised for issue by the Director on 27 August 2024, and are signed on its behalf by:
Mr Benjamin AMPOMAH
Director
Registered Company No. 00686142
ALAN STOCKLEY & COMPANY LIMITED
Notes to the Financial Statements
for the year ended 30 November 2023

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The address of the registered office is The Pharmacy, 37 Lynn Road, Snettisham, Kings Lynn, PE31 7LR, Norfolk.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Revenue from sale of goods
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)
Land and buildings15
Plant and machinery15
Vehicles25
Stocks and work in progress
Inventories are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
2.Average number of employees

20232022
Average number of employees during the year1313
3.Tangible fixed assets

Land & buildings

Plant & machinery

Vehicles

Total

££££
Cost or valuation
At 01 December 2260,85675,490-136,346
Additions--8,3548,354
At 30 November 2360,85675,4908,354144,700
Depreciation and impairment
At 01 December 2230,32264,730-95,052
Charge for year4,5801,6141,4037,597
At 30 November 2334,90266,3441,403102,649
Net book value
At 30 November 2325,9549,1466,95142,051
At 30 November 2230,53410,760-41,294
4.Stocks

2023

2022

££
Finished goods79,22262,350
Total79,22262,350
5.Debtors: amounts due within one year

2023

2022

££
Trade debtors / trade receivables251,595246,138
Amounts owed by group undertakings633,958532,458
Other debtors15,03817,576
Prepayments and accrued income284311
Total900,875796,483
6.Creditors: amounts due within one year

2023

2022

££
Trade creditors / trade payables219,412206,277
Bank borrowings and overdrafts10,00010,000
Amounts owed to related parties58,97124,000
Taxation and social security34,79537,819
Other creditors122,736112,916
Accrued liabilities and deferred income21,00133,500
Total466,915424,512
7.Creditors: amounts due after one year

2023

2022

££
Bank borrowings and overdrafts23,17433,333
Total23,17433,333
8.Related party transactions
At the year-end, Ben Amp Holdings Ltd owed £633,958 (PE Nov 2022: £531,958) to Alan Stockley & Company Ltd. Alan Stockley & Company Ltd owed £34,607 (PE Nov 2022: £24,000) to A.B. Chemist Ltd and £24,364 (PE Nov 23: DR £500) to The Chemist Shop Ltd. The companies are related as Mr. Benjamin Ampomah is also a director in these companies.